Omega-3 is a supportive supplement for PCOS with the best evidence around insulin-resistance markers, triglycerides, and inflammation. It makes most sense as a metabolic support option rather than a broad symptom supplement.
Promising for metabolic and inflammation support, but not one of the strongest all-round PCOS supplements.
Omega-3 usually refers to long-chain fatty acids such as EPA and DHA, most often from fish oil. In PCOS, the main rationale is support for triglycerides, insulin-related markers, and low-grade inflammation, which is why it fits better as a metabolic support supplement than as a symptom-specific one.
A practical option is a product that clearly states its omega-3 content per daily serving and can reach the 2 to 4 g/day studied range without an impractical capsule burden. Taking it with food is usually the most practical approach, especially for tolerance. A sensible review point is 8 to 12 weeks.
Omega-3 is usually well tolerated, but mild side effects can include reflux, nausea, loose stools, bad taste, or fishy aftertaste. General safety guidance notes that EPA+DHA intakes up to about 5 g/day appear safe for most people, but extra caution is sensible with blood thinners, around surgery, and in people with a history of atrial fibrillation.
Omega-3 was linked to lower CRP, MDA, LH and total testosterone, and higher TAC and SHBG. This suggests possible endocrine and inflammatory benefit, but not proven symptom improvement.
Omega-3 improved insulin, HOMA-IR, triglycerides, total cholesterol, LDL-C and HDL-C, but did not significantly change fasting glucose.
Omega-3 lowered hs-CRP and increased adiponectin, suggesting anti-inflammatory benefit in PCOS. It did not clearly improve visfatin, nitric oxide, glutathione, MDA or TAC.
Omega-3 improved HOMA-IR, total cholesterol, triglycerides and adiponectin versus control, supporting modest metabolic benefit in PCOS rather than symptom-specific benefit.
In clomiphene-treated women with PCOS, omega-3 increased clinical pregnancy per treatment cycle, especially in overweight or obese participants, with no harmful side effects reported.
Fish oil improved inflammatory gene-expression markers in PBMCs, supporting a plausible anti-inflammatory effect in PCOS.
In overweight or obese women with PCOS, omega-3 increased adiponectin and improved insulin resistance and several lipid markers versus placebo over 8 weeks.
Fish oil lowered triglycerides, but worsened some dynamic glucose measures over 6 weeks, showing formulation-specific effects and a mixed metabolic signal.
In overweight women with PCOS, 4 g/day omega-3 for 8 weeks reduced liver fat, triglycerides and blood pressure versus placebo.
Omega-3 has some of its best PCOS evidence in inflammation-related biomarkers. Reviews have found improvements in markers such as hs-CRP and adiponectin, which supports its role as an anti-inflammatory add-on. That does not mean it will noticeably change every symptom, but inflammation support is one of its clearer strengths.
Omega-3 looks most useful in PCOS as a supportive metabolic supplement. The strongest evidence points to improvements in triglycerides, some insulin-resistance markers such as insulin and HOMA-IR, and some inflammatory markers like hs-CRP and adiponectin. It is better viewed as a supportive add-on than a stand-alone solution.
Several PCOS meta-analyses found improvements in insulin and HOMA-IR, which suggests omega-3 may support insulin resistance in some women with PCOS. The evidence is not perfect, and not every glucose-related marker improved consistently, but this is one of the strongest reasons to consider omega-3 on a PCOS supplement page.
For PCOS, omega-3 makes the most sense when the goal is supporting metabolic markers, especially insulin resistance, triglycerides, and low-grade inflammation. It is less convincing as a broad supplement for every PCOS symptom, so it tends to fit best as part of a wider strategy rather than as a main supplement on its own.
Evidence-led, supportive PCOS guidance - without pressure or perfection.
Information on this site is for educational purposes only and is not a substitute for medical advice.